Trevi Therapeutics, Inc.
TRVI·89532M101·US·Common Stock·Healthcare - Biotechnology-Activist
TRVI (Trevi Therapeutics, Inc.) is held by 110 institutional investors as of Q2 2026. Largest holders: FMR LLC ($234.3M), BlackRock, Inc. ($208M), WELLINGTON MANAGEMENT GROUP LLP ($106M). Net institutional sentiment: Mixed.
110
Holders
(8 Elite)
$1.4B
Total Value
66% (117)
Consensus
77 buying - 40 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Mar 26, 2025 · Activists Aug 6, 2026 · Congress none
ActivistNENew Enterprise Associates 16, L.P.10.5%May 7, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 122
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer